Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01369225
What this trial is testing

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 52
Early research (Phase 1)Study completedNCT03635047
What this trial is testing

A Phase I Study for Safety and Tolerability of AL002.

Who this might be right for
HealthyAlzheimer Disease
Alector Inc. 69
Early research (Phase 1)Study completedNCT01850238
What this trial is testing

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Axon Neuroscience SE 30
Post-approval studies (Phase 4)Study completedNCT02787746
What this trial is testing

Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Beijing Friendship Hospital 241
Testing effectiveness (Phase 2)Study completedNCT00257673
What this trial is testing

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Memory Pharmaceuticals 183
Testing effectiveness (Phase 2)Study completedNCT03055741
What this trial is testing

Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)

Who this might be right for
Mild-moderate Alzheimer's Disease
Daehwa Pharmaceutical Co., Ltd. 180
Large-scale testing (Phase 3)Study completedNCT00053599
What this trial is testing

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA) 400
Large-scale testing (Phase 3)Looking for participantsNCT06976203
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Large-scale testing (Phase 3)Ended earlyNCT02327182
What this trial is testing

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 117
Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT01436045
What this trial is testing

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Who this might be right for
Alzheimer's Disease
HealthPartners Institute 12
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Testing effectiveness (Phase 2)Study completedNCT02626572
What this trial is testing

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

Who this might be right for
Alzheimer's Disease
Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Looking for participantsNCT06534723
What this trial is testing

Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Who this might be right for
Alzheimer's Dementia
Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Early research (Phase 1)Study completedNCT00607308
What this trial is testing

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 20
Early research (Phase 1)Study completedNCT01908010
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT00357357
What this trial is testing

European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Hunter-Fleming Ltd 40
Large-scale testing (Phase 3)WithdrawnNCT00743743
What this trial is testing

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Medical College of Wisconsin
Large-scale testing (Phase 3)Study completedNCT02006641
What this trial is testing

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 858
Testing effectiveness (Phase 2)Study completedNCT01504854
What this trial is testing

Resveratrol for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 119
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation